全文获取类型
收费全文 | 687篇 |
免费 | 40篇 |
国内免费 | 5篇 |
专业分类
耳鼻咽喉 | 6篇 |
儿科学 | 26篇 |
妇产科学 | 28篇 |
基础医学 | 61篇 |
口腔科学 | 21篇 |
临床医学 | 65篇 |
内科学 | 222篇 |
皮肤病学 | 19篇 |
神经病学 | 39篇 |
特种医学 | 5篇 |
外科学 | 63篇 |
综合类 | 14篇 |
一般理论 | 1篇 |
预防医学 | 62篇 |
眼科学 | 14篇 |
药学 | 51篇 |
中国医学 | 3篇 |
肿瘤学 | 32篇 |
出版年
2024年 | 1篇 |
2023年 | 12篇 |
2022年 | 13篇 |
2021年 | 34篇 |
2020年 | 28篇 |
2019年 | 27篇 |
2018年 | 28篇 |
2017年 | 18篇 |
2016年 | 33篇 |
2015年 | 20篇 |
2014年 | 35篇 |
2013年 | 63篇 |
2012年 | 64篇 |
2011年 | 61篇 |
2010年 | 31篇 |
2009年 | 33篇 |
2008年 | 57篇 |
2007年 | 49篇 |
2006年 | 33篇 |
2005年 | 30篇 |
2004年 | 17篇 |
2003年 | 17篇 |
2002年 | 7篇 |
2001年 | 5篇 |
2000年 | 6篇 |
1999年 | 5篇 |
1997年 | 2篇 |
1994年 | 1篇 |
1989年 | 1篇 |
1970年 | 1篇 |
排序方式: 共有732条查询结果,搜索用时 31 毫秒
1.
2.
3.
Sulkowski MS Felizarta F Smith C Slim J Berggren R Goodman R Ball L Khalili M Dieterich DT;Hepatitis Resource Network Clinical Trials Group 《Journal of acquired immune deficiency syndromes (1999)》2004,35(5):464-472
Among HIV-infected persons, chronic hepatitis C virus (HCV) infection causes substantial morbidity and mortality. However, few studies have evaluated the safety and efficacy of interferon alfa (IFN) and ribavirin (RBV) therapy in co-infected persons. Accordingly, a randomized, controlled, open-label, multicenter trial was conducted to establish the safety, tolerability, and efficacy of IFN alfa-2b 3 mIU daily plus RBV 800 mg/d compared with IFN alfa-2b 3 mIU thrice weekly (TIW) plus RBV 800 mg/d in HCV treatment-naive, HIV-infected subjects with compensated liver disease and stable HIV disease. The primary endpoint was sustained virologic response (SVR), defined as an undetectable HCV RNA level 24 weeks after discontinuation of HCV therapy. At study entry, subjects in both groups were similar with respect to age, gender, HCV genotype, and HIV disease status. Of 180 randomized subjects, 162 received at least 1 dose of study medication, constituting the modified intention-to-treat population. After 12 weeks of therapy, 122 (75%) had serum HCV RNA levels assessed; of these subjects, early virologic response (undetectable HCV RNA or >2 log10 decrease from baseline) was observed in 33 (42%) and 13 (16%) of subjects taking daily and TIW IFN, respectively (P < 0.001). SVR was observed in 15 (19.0%) and 7 (8.4%) of subjects taking daily and TIW IFN, respectively (P = 0.05). Adverse events were similar in both groups. However, while no deaths or opportunistic infections were observed, nearly 30% of subjects stopped treatment due to adverse events and 7 subjects experienced a serious adverse event. In conclusion, SVR was achieved in 19% of HIV/HCV coinfected subjects treated with daily IFN plus RBV, but the effectiveness of therapy was substantially diminished by relatively high rates of treatment-related toxicity. 相似文献
4.
Basnet Sulochana Frongillo Edward A. Nguyen Phuong Hong Moore Spencer Arabi Mandana 《Maternal and child health journal》2021,25(6):946-946
Maternal and Child Health Journal - The article “Factor Structure and Equivalence of Maternal Resources for Care in Bangladesh, Vietnam, and Ethiopia”, written by Sulochana Basnet,... 相似文献
5.
Swiatek V. M. Stein K.-P. Cukaz H. B. Rashidi A. Skalej M. Mawrin C. Sandalcioglu I. E. Neyazi B. 《Neurosurgical review》2021,44(4):1833-1852
Neurosurgical Review - Intramedullary schwannomas (IMS) represent exceptional rare pathologies. They commonly present as solitary lesions; only five cases of multiple IMS have been described so... 相似文献
6.
Kiani Zahra Simbar Masoumeh Nazarpour Soheila Rashidi Fakari Farzaneh 《Archives of sexual behavior》2022,51(7):3223-3224
Archives of Sexual Behavior - 相似文献
7.
L. A. France C. A. Scotchford D. M. Grant H. Rashidi A. A. Popov V. Sottile 《Journal of tissue engineering and regenerative medicine》2014,8(8):652-663
Human mesenchymal stem cells (MSCs), which can generate both osteoblasts and chondrocytes, represent an ideal resource for orthopaedic repair using tissue‐engineering approaches. One major difficulty for the development of osteochondral constructs using undifferentiated MSCs is that serum is typically used in culture protocols to promote differentiation of the osteogenic component, whereas existing chondrogenic differentiation protocols rely on the use of serum‐free conditions. In order to define conditions which could be compatible with both chondrogenic and osteogenic differentiation in a single bioreactor, we have analysed the efficiency of new biphasic differentiation regimes based on transient serum exposure followed by serum‐free treatment. MSC differentiation was assessed either in serum‐free medium or with a range of transient exposure to serum, and compared to continuous serum‐containing treatment. Although osteogenic differentation was not supported in the complete absence of serum, marker expression and extensive mineralization analyses established that 5 days of transient exposure triggered a level of differentiation comparable to that observed when serum was present throughout. This initial phase of serum exposure was further shown to support the successful chondrogenic differentiation of MSCs, comparable to controls maintained in serum‐free conditions throughout. This study indicates that a culture based on temporal serum exposure followed by serum‐free treatment is compatible with both osteogenic and chondrogenic differentiation of MSCs. These results will allow the development of novel strategies for osteochondral tissue engineering approaches using MSCs for regenerative medicine. Copyright © 2012 John Wiley & Sons, Ltd. 相似文献
8.
Nasrin Mirzaei Farkhondeh Poursina Sharareh Moghim Niloufar Rashidi 《Critical reviews in microbiology》2017,43(5):631-650
Helicobacter pylori has grown to colonize inside the stomach of nearly half of the world’s population, turning into the most prevalent infections in the universe. Medical care failures noticeably confirm the need for a vaccine to hinder or deal with H. pylori. This review is planned to discuss the most known factors as a vaccine candidate, including single (AhpC, BG, CagA, KatA, Fla, Hsp, HWC, Lpp, LPS, NAP, OMP, OMV, SOD, Tpx, Urease, VacA) and multi-component vaccines. Many promising results in the field of single and multivalent vaccine can be seen, but there is no satisfactory outcome and neither a prophylactic nor a therapeutic vaccine to treat or eradicate the infection in human has been acquired. Hence, selecting suitable antigen is an important factor as an appropriate adjuvant. Taken all together, the development of efficient anti-H. pylori vaccines relies on the fully understanding of the interactions between H. pylori and its host immune system. Therefore, more work should be done on epitope mapping, analysis of molecular structure, and determination of the antigen determinant region as well due to design a vaccine, preferably a multi-component vaccine to elicit specific CD4 T-cell responses that are required for H. pylori vaccine efficacy. 相似文献
9.
10.